Inicio › Mieloma múltiple › Connecticut › New Haven
Ensayos clínicos de Mieloma múltiple en New Haven, CT
13 estudios para Mieloma múltiple buscan participantes en centros de New Haven y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma
ReclutandoFase 3
- Yale University, New Haven
Engaging T-cells to Eliminate MRD in Newly Diagnosed Myeloma Optimizing Response With Talquetmab and Teclistamab (ROTATE)
ReclutandoFase 2
- Yale University, New Haven
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
ReclutandoFase 3
- Yale New Haven Hospital, New Haven
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
ReclutandoFase 3
- Yale Cancer Center, New Haven
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
ReclutandoFase 1/2
- Yale University School of Medicine /ID# 272447, New Haven
Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma
ReclutandoFase 1
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · A 7 mi de distancia
- Smilow Cancer Hospital-Derby Care Center, Derby · A 8 mi de distancia
- y 1 más
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
ReclutandoFase 3
- Research Site, New Haven
A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events
ReclutandoFase 2
- Yale University School Of Medicine, New Haven
A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma
ReclutandoFase 1/2
- Yale New Haven Hospital-Smilow Cancer Center, New Haven
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
ReclutandoFase 3
- Smilow Cancer Center/Yale-New Haven Hospital, New Haven
- Yale University, New Haven
- Smilow Cancer Hospital-Orange Care Center, Orange · A 5 mi de distancia
- y 3 más
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
ReclutandoFase 3
- Research Site, New Haven
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
ReclutandoFase 3
- Smilow Cancer Center/Yale-New Haven Hospital, New Haven
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · A 7 mi de distancia
- y 2 más
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
ReclutandoFase 1
- Yale Cancer Center, New Haven
Más información sobre Mieloma múltiple en MedlinePlus
Ensayos de Mieloma múltiple en otras ciudades
- New York City, NY59 estudios
- Boston, MA45 estudios
- Atlanta, GA42 estudios
- Houston, TX39 estudios
- Durham, NC36 estudios
- Nashville, TN31 estudios
- Denver, CO26 estudios
- St. Louis, MO26 estudios
- Rochester, MN25 estudios
- Columbus, OH25 estudios
- Chicago, IL24 estudios
- Milwaukee, WI23 estudios
Otros estudios en New Haven
- Cáncer de pulmón de células no pequeñas40 estudios
- Cáncer de seno38 estudios
- Cáncer (todos los tipos)35 estudios
- Cáncer de pulmón24 estudios
- Cáncer del colon y del recto23 estudios
- Carcinoma de células escamosas de cabeza y cuello22 estudios
- Cáncer metastásico22 estudios
- Cáncer de próstata22 estudios
- Cáncer de ovario20 estudios
- Sobredosis de opioides19 estudios
- Leucemia mielógena aguda18 estudios
- Trastorno por consumo de alcohol18 estudios
De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.